FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2979508462> ?p ?o ?g. }

• W2979508462 endingPage "S1545" @default.
• W2979508462 startingPage "S1544" @default.
• W2979508462 abstract "INTRODUCTION: Background: Primary sclerosing cholangitis (PSC) is a cholestatic liver disease with no current effective therapy. Ursodeoxycholic acid (UDCA) is often used, however it does not slow disease progression despite improvement in serum alkaline phosphatase (ALP). Fenofibrate (FF) improves cholestasis in patients with primary biliary cholangitis (PBC). We present a retrospective single-center case series of Fenofibrate in PSC patients. METHODS: Methods: Patients were identified within a Liver Registry with large-duct PSC on FF. Overlap cases with PBC or autoimmune hepatitis were excluded. The mean age at diagnosis was 39.7 ± 19.2 years; 4 were males, 5 Caucasian and 2 Hispanic. Five had inflammatory bowel disease, five had intra/extrahepatic disease and two had intrahepatic disease. All patients received UDCA. FF was added 5-396 months post diagnosis. RESULTS: Mean ALP pre-FF was 654 U/L ± 646 and after 4-6 months improved by a mean of 176 ± 263.4 U/L; 4/7 patients had ALP reduction with FF and 3 achieved a normal ALP level (Figure 1). MRI post FF was available in five patients; 3 had worsening of strictures after 6-12 months of FF while 2/5 were stable). ERCP was performed for stricture management on 4 patients and 2 required repeat ERCP. One patient developed cirrhosis; no patients developed ascites, encephalopathy, cholangiocarcinoma or hepatocellular carcinoma. One patient had a transplant evaluation for refractory pruritus. Of four with pruritus pre-FF, 1; one had moderate improvement. Of 6 patients with fatigue, 3 had persistence post-FF and 1 had new fatigue. Of 3 patients who had cholangitis pre-FF, 2 had recurrent episodes post-FF. No patients developed myopathy or acute kidney injury. FF was discontinued in one patient due to lack of ALP improvement at 6 months. Amsterdam-Oxford Risk Score (Figure 2) was calculated at time of FF, 4-6 months after FF, and at 1- and 2- years for those with data beyond 6 months. Among the 4 patients with ALP improvement, there was mild improvement in the risk score (not sustained beyond 2 years in 3 patients). CONCLUSION: Conclusion: This case series suggests a potential use for FF in the treatment of PSC. However, despite reduction in ALP, fatigue, pruritus, and recurrent cholangitis persisted and FF did not improve strictures, similar to UDCA studies in PSC. Future aims of this study involve examining elastography data pre- and post-FF. The role of FF in PSC treatment should be examined in larger, longitudinal studies." @default.
• W2979508462 created "2019-10-18" @default.
• W2979508462 creator A5014348793 @default.
• W2979508462 creator A5020017677 @default.
• W2979508462 creator A5043933285 @default.
• W2979508462 creator A5047186883 @default.
• W2979508462 date "2019-10-01" @default.
• W2979508462 modified "2023-09-23" @default.
• W2979508462 title "2797 Fenofibrate and PSC: A Case Series From a Single Center Liver Registry" @default.
• W2979508462 doi "https://doi.org/10.14309/01.ajg.0000600720.33625.bb" @default.
• W2979508462 hasPublicationYear "2019" @default.
• W2979508462 type Work @default.
• W2979508462 sameAs 2979508462 @default.
• W2979508462 citedByCount "0" @default.
• W2979508462 crossrefType "journal-article" @default.
• W2979508462 hasAuthorship W2979508462A5014348793 @default.
• W2979508462 hasAuthorship W2979508462A5020017677 @default.
• W2979508462 hasAuthorship W2979508462A5043933285 @default.
• W2979508462 hasAuthorship W2979508462A5047186883 @default.
• W2979508462 hasBestOaLocation W29795084621 @default.
• W2979508462 hasConcept C126322002 @default.
• W2979508462 hasConcept C160160445 @default.
• W2979508462 hasConcept C181199279 @default.
• W2979508462 hasConcept C185592680 @default.
• W2979508462 hasConcept C2777075537 @default.
• W2979508462 hasConcept C2777969384 @default.
• W2979508462 hasConcept C2778110834 @default.
• W2979508462 hasConcept C2778593092 @default.
• W2979508462 hasConcept C2779134260 @default.
• W2979508462 hasConcept C2780073493 @default.
• W2979508462 hasConcept C2780366471 @default.
• W2979508462 hasConcept C2780496750 @default.
• W2979508462 hasConcept C2780615123 @default.
• W2979508462 hasConcept C2780965833 @default.
• W2979508462 hasConcept C55493867 @default.
• W2979508462 hasConcept C71924100 @default.
• W2979508462 hasConcept C90924648 @default.
• W2979508462 hasConceptScore W2979508462C126322002 @default.
• W2979508462 hasConceptScore W2979508462C160160445 @default.
• W2979508462 hasConceptScore W2979508462C181199279 @default.
• W2979508462 hasConceptScore W2979508462C185592680 @default.
• W2979508462 hasConceptScore W2979508462C2777075537 @default.
• W2979508462 hasConceptScore W2979508462C2777969384 @default.
• W2979508462 hasConceptScore W2979508462C2778110834 @default.
• W2979508462 hasConceptScore W2979508462C2778593092 @default.
• W2979508462 hasConceptScore W2979508462C2779134260 @default.
• W2979508462 hasConceptScore W2979508462C2780073493 @default.
• W2979508462 hasConceptScore W2979508462C2780366471 @default.
• W2979508462 hasConceptScore W2979508462C2780496750 @default.
• W2979508462 hasConceptScore W2979508462C2780615123 @default.
• W2979508462 hasConceptScore W2979508462C2780965833 @default.
• W2979508462 hasConceptScore W2979508462C55493867 @default.
• W2979508462 hasConceptScore W2979508462C71924100 @default.
• W2979508462 hasConceptScore W2979508462C90924648 @default.
• W2979508462 hasIssue "1" @default.
• W2979508462 hasLocation W29795084621 @default.
• W2979508462 hasLocation W29795084622 @default.
• W2979508462 hasOpenAccess W2979508462 @default.
• W2979508462 hasPrimaryLocation W29795084621 @default.
• W2979508462 hasRelatedWork W155356038 @default.
• W2979508462 hasRelatedWork W2008803377 @default.
• W2979508462 hasRelatedWork W2024251369 @default.
• W2979508462 hasRelatedWork W2043493714 @default.
• W2979508462 hasRelatedWork W2117204309 @default.
• W2979508462 hasRelatedWork W2188494716 @default.
• W2979508462 hasRelatedWork W2354922977 @default.
• W2979508462 hasRelatedWork W2469683173 @default.
• W2979508462 hasRelatedWork W3121023222 @default.
• W2979508462 hasRelatedWork W4253454288 @default.
• W2979508462 hasVolume "114" @default.
• W2979508462 isParatext "false" @default.
• W2979508462 isRetracted "false" @default.
• W2979508462 magId "2979508462" @default.
• W2979508462 workType "article" @default.